Bath & Body Works, Inc.

Bath & Body Works, Inc. has faced notable stock volatility, with significant declines over the past week and month. The company reports challenges in long-term financial metrics, including decreasing net sales and low operating profit growth. Its market performance has consistently lagged behind the S&P 500, indicating a difficult environment.

Bath & Body Works, Inc. opened with a notable loss, reflecting volatility in the small-cap footwear sector. The stock has declined significantly over the past month, contrasting with the S&P 500's performance. Financial metrics indicate challenges, including a negative return on equity and a complex debt-to-equity ratio.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 6.3 billion, faces challenges such as decreasing net sales and low return on equity, indicating underlying financial weaknesses.

Bath & Body Works, Inc. has hit a new 52-week low, trading at USD 21.37 as of November 17, 2025, reflecting a significant decline in stock value over the past year. The company faces challenges, including a low P/E ratio, negative book value, and declining net sales.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in performance over the past year. The company faces financial challenges, including a low P/E ratio, negative book value, and a substantial drop in net sales, while also showing modest operating profit growth.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces challenges, including a low price-to-earnings ratio, negative book value, and a concerning annual net sales growth rate, indicating ongoing financial difficulties.

Bath & Body Works, Inc. has hit a new 52-week low, trading at USD 22.38 as of November 7, 2025, following a 49.79% decline in stock price over the past year. The company faces financial challenges, including decreasing net sales and a concerning return on equity.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in performance over the past year. The company faces financial challenges, including a low P/E ratio, negative return on equity, and decreasing net sales, while its stock has consistently underperformed compared to the S&P 500.

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 23.40 as of November 4, 2025. The company has faced a significant decline in performance over the past year, with a notable drop in net sales and ongoing financial challenges, including a negative book value.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in performance over the past year. The company faces financial challenges, including negative return on equity and a concerning debt-to-equity ratio. Additionally, net sales have decreased, contributing to its underperformance compared to market benchmarks.

Bath & Body Works, Inc. has hit a new 52-week low, trading at USD 23.79 as of October 30, 2025, following a 47.56% decline over the past year. The company faces financial challenges, including a low P/E ratio, negative book value, and declining net sales.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces challenges such as a negative book value, low return on equity, and declining net sales, indicating a difficult financial environment.

Bath & Body Works, Inc. has hit a new 52-week low, trading at USD 24.86 as of October 10, 2025, reflecting a 45.17% decline in stock price over the past year. The company faces financial challenges, including negative return on equity and declining net sales.

Bath & Body Works, Inc. has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including negative return on equity and a high debt-to-equity ratio, while also experiencing a decrease in net sales.